Valuation : ALTEOGEN Inc.

Market Cap 20,089B 14.92B 12.84B 12.08B 11.03B 20.64B 1,408B 20.69B 143B 55.38B 723B 56.01B 54.79B 2,328B P/E 2026 *
67.4x
P/E 2027 * 49.6x
Enterprise Value 19.6B 14.55M 12.52M 11.78M 10.76M 20.13M 1.37B 20.19M 139M 54.02M 705M 54.64M 53.45M 2.27B EV / Sales 2026 *
41.7x
EV / Sales 2027 * 29.3x
Free-Float
74.26%
Yield 2026 *
0.16%
Yield 2027 * 0.19%
1 day+1.94%
1 week-9.84%
Current month-6.18%
1 month+4.15%
3 months+12.80%
6 months+0.82%
Current year-16.56%
1 week 282,000
Extreme 282000
329,000
1 month 282,000
Extreme 282000
356,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 32,653.85
Extreme 32653.846153
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 26/12/2025
Director of Finance/CFO 61 28/03/2023
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 13/05/2008
Director/Board Member 70 29/03/2021
Director/Board Member 61 28/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
5/21/25 A Exercice

Chief Executive Officer

7,200 0.0135%
3/27/24 A Sell 1,600,000 3.0182%
1/5/24 A Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+1.94%-9.84%-21.13%+779.37% 14.92B
-1.87%+4.22%+44.36%+0.58% 82.65B
-0.57%+1.27%-16.61%-35.57% 60.24B
-2.23%+5.48%+478.96%+33.09% 58.11B
-2.03%-2.62%-8.63%+27.87% 49.68B
-4.58%-2.73%+1.79%+159.87% 46.66B
-1.64%+1.07%+56.98%-17.07% 32.63B
-0.98%+1.91%+46.30%+100.30% 25.69B
-0.19%-4.74%-0.68%+194.68% 22.73B
-1.13%-2.45%+64.66%+108.24% 16.51B
Average -1.33%-0.83%+64.60%+135.14% 40.98B
Weighted average by Cap. -1.72%+0.49%+82.81%+69.62%

Financials

2026 *2027 *
Net sales 470B 349M 300M 283M 258M 483M 32.95B 484M 3.34B 1.3B 16.91B 1.31B 1.28B 54.46B 660B 490M 422M 397M 363M 678M 46.29B 680M 4.69B 1.82B 23.75B 1.84B 1.8B 76.51B
Net income 296B 220M 189M 178M 163M 305M 20.79B 305M 2.11B 817M 10.66B 827M 809M 34.36B 377B 280M 241M 227M 207M 388M 26.45B 389M 2.68B 1.04B 13.57B 1.05B 1.03B 43.71B
Net Debt -493B -366M -315M -296M -271M -506M -34.54B -508M -3.5B -1.36B -17.72B -1.37B -1.34B -57.1B -755B -561M -482M -454M -415M -776M -52.94B -778M -5.36B -2.08B -27.16B -2.11B -2.06B -87.5B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
04/09/26 ₩288,500.00 +1.94% 613,855
03/09/26 ₩283,000.00 -5.19% 1,248,714
02/09/26 ₩298,500.00 -0.83% 2,219,578
01/09/26 ₩301,000.00 -2.11% 281,391
31/08/26 ₩307,500.00 -3.91% 656,406
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
288,500.00KRW
Average target price
382,051.28KRW
Spread / Average Target
+32.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock